HealthEquity (HQY) | Financial Analysis & Statements
HealthEquity Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
334.6M
Gross Profit
228.1M
68.19%
Operating Income
72.4M
21.64%
Net Income
49.7M
14.87%
EPS (Diluted)
$0.58
Balance Sheet Metrics
Total Assets
3.4B
Total Liabilities
1.3B
Shareholders Equity
2.1B
Debt to Equity
0.60
Cash Flow Metrics
Operating Cash Flow
109.5M
Free Cash Flow
107.8M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2026
HealthEquity Income Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.2B | 999.6M | 861.7M | 756.6M |
| Cost of Goods Sold | 400.3M | 422.5M | 377.0M | 369.8M | 331.8M |
| Gross Profit | 913.1M | 777.3M | 622.6M | 491.9M | 424.8M |
| Gross Margin % | 69.5% | 64.8% | 62.3% | 57.1% | 56.1% |
| Operating Expenses | |||||
| Research & Development | 262.5M | 239.5M | 218.8M | 193.4M | 157.4M |
| Selling, General & Administrative | 215.2M | 223.0M | 182.9M | 166.3M | 144.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 477.7M | 462.5M | 401.7M | 359.7M | 301.4M |
| Operating Income | 327.5M | 202.9M | 128.1M | 37.7M | 40.6M |
| Operating Margin % | 24.9% | 16.9% | 12.8% | 4.4% | 5.4% |
| Non-Operating Items | |||||
| Interest Income | 11.7M | 13.9M | 12.1M | 1.8M | 1.5M |
| Interest Expense | 57.1M | 60.6M | 55.5M | 48.4M | 36.6M |
| Other Non-Operating Income | -4.6M | -40.1M | -9.8M | -29.1M | -72.2M |
| Pre-tax Income | 277.4M | 116.0M | 75.0M | -38.1M | -66.7M |
| Income Tax | 62.2M | 19.3M | 19.3M | -12.0M | -22.5M |
| Effective Tax Rate % | 22.4% | 16.7% | 25.8% | 0.0% | 0.0% |
| Net Income | 215.2M | 96.7M | 55.7M | -26.1M | -44.3M |
| Net Margin % | 16.4% | 8.1% | 5.6% | -3.0% | -5.9% |
| Key Metrics | |||||
| EBITDA | 494.2M | 379.7M | 294.0M | 200.2M | 181.0M |
| EPS (Basic) | $2.50 | $1.11 | $0.65 | $-0.31 | $-0.53 |
| EPS (Diluted) | $2.46 | $1.09 | $0.64 | $-0.31 | $-0.53 |
| Basic Shares Outstanding | 86132000 | 86870000 | 85564000 | 84442000 | 83133000 |
| Diluted Shares Outstanding | 86132000 | 86870000 | 85564000 | 84442000 | 83133000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
HealthEquity Balance Sheet From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 318.9M | 295.9M | 404.0M | 254.3M | 225.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 123.7M | 118.0M | 104.9M | 96.8M | 87.4M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 69.7M | 63.8M | 48.6M | 31.8M | 38.5M |
| Total Current Assets | 512.3M | 477.7M | 557.4M | 382.9M | 351.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 36.3M | 43.2M | 48.4M | 56.5M | 63.6M |
| Goodwill | 4.4B | 4.5B | 4.1B | 4.2B | 4.3B |
| Intangible Assets | 1.1B | 1.2B | 835.9M | 936.4M | 973.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 83.2M | 71.6M | 67.9M | 52.2M | 49.8M |
| Total Non-Current Assets | 2.9B | 3.0B | 2.6B | 2.7B | 2.8B |
| Total Assets | 3.4B | 3.4B | 3.2B | 3.1B | 3.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 12.2M | 14.4M | 12.0M | 13.9M | 27.5M |
| Short-term Debt | 9.9M | 10.0M | 9.4M | 27.7M | 20.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 156.8M | 156.3M | 117.1M | 131.1M | 153.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 991.6M | 1.1B | 923.7M | 966.8M | 987.3M |
| Deferred Tax Liabilities | 93.7M | 55.8M | 68.7M | 82.7M | 99.8M |
| Other Non-Current Liabilities | 31.0M | 23.0M | 19.3M | 12.7M | 14.2M |
| Total Non-Current Liabilities | 1.1B | 1.2B | 1.0B | 1.1B | 1.1B |
| Total Liabilities | 1.3B | 1.3B | 1.1B | 1.2B | 1.3B |
| Equity | |||||
| Common Stock | 8.0K | 9.0K | 9.0K | 8.0K | 8.0K |
| Retained Earnings | 195.9M | 209.3M | 205.6M | 149.9M | 176.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.1B | 2.1B | 2.0B | 1.9B | 1.9B |
| Key Metrics | |||||
| Total Debt | 1.0B | 1.1B | 933.1M | 994.5M | 1.0B |
| Working Capital | 355.4M | 321.4M | 440.3M | 251.8M | 198.2M |
Balance Sheet Composition
HealthEquity Cash Flow Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 215.2M | 96.7M | 55.7M | -26.1M | -44.3M |
| Depreciation & Amortization | 154.7M | 162.5M | 153.1M | 161.2M | 137.2M |
| Stock-Based Compensation | 73.1M | 96.4M | 77.2M | 62.6M | 52.8M |
| Working Capital Changes | -26.6M | -6.5M | -33.1M | -33.4M | 1.6M |
| Operating Cash Flow | 457.1M | 338.3M | 241.7M | 150.6M | 127.4M |
| Investing Activities | |||||
| Capital Expenditures | -2.0M | -2.1M | -1.7M | -3.4M | -8.9M |
| Acquisitions | - | - | 0 | 0 | -504.5M |
| Investment Purchases | - | - | - | - | 0 |
| Investment Sales | 1.6M | - | 0 | 0 | 2.4M |
| Investing Cash Flow | -332.0K | -2.1M | -1.7M | -3.4M | -511.1M |
| Financing Activities | |||||
| Share Repurchases | -299.3M | -121.5M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 736.9M | 0 | 0 | 950.0M |
| Debt Repayment | -100.0M | -561.9M | -54.4M | -8.8M | -1.0B |
| Financing Cash Flow | -398.4M | 48.1M | -53.5M | -9.4M | 385.1M |
| Free Cash Flow | 408.3M | -165.6M | 196.8M | 31.5M | 3.9M |
| Net Change in Cash | 58.4M | 384.3M | 186.5M | 137.9M | 1.4M |
Cash Flow Trend
HealthEquity Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
31.61
Forward P/E
14.56
Price to Book
3.14
Price to Sales
5.00
PEG Ratio
0.34
Profitability Ratios
Profit Margin
16.39%
Operating Margin
21.64%
Return on Equity
10.19%
Return on Assets
5.99%
Financial Health
Current Ratio
3.27
Debt to Equity
47.53
Beta
0.26
Per Share Data
EPS (TTM)
$2.46
Book Value per Share
$24.79
Revenue per Share
$15.25
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HQY | 6.6B | 31.61 | 3.14 | 10.19% | 16.39% | 47.53 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Tempus AI | 9.4B | 39.30 | 18.89 | -89.48% | -19.27% | 270.11 |
| BrightSpring Health | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
| Waystar Holding | 4.8B | 40.74 | 1.23 | 3.22% | 10.20% | 38.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.






